Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

In the Research Article "Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments" by Bilodeau et al., 1 row 24 of Table 2 should be labeled "Serious infections."The updated Table follows.The authors regret the error.